By Sharon Zhang, Truthout
A new analysis by Public Citizen found that the U.S. is spending nearly double what the rest of the world spends combined for key drugs. The report offers further evidence that the country is in dire need of pharmaceutical drug price reformation, which progressives are fighting for through the Build Back Better Act.
The report finds that, for the 20 top-selling drugs worldwide, U.S. sales totaled $101.1 billion, while sales of the same drugs to the rest of the world totaled almost $57 billion in 2020. For 11 of the drugs, revenue in the U.S. was double that of the rest of the world combined. And for 11 of the 13 pharmaceutical companies that sell these drugs, U.S. profits made up most of their revenue.
Recent Posts
Bombing Iran Is Part Of The USA’s Repetition Compulsion For War War War
June 22, 2025
Take Action Now More than ever, the United States and Israel are overt partners in what the Nuremberg Tribunal in 1946 called “the supreme…
62 percent Of Democrats Agree Party Leadership Should Be Replaced: Survey
June 20, 2025
Take Action Now The party has found it difficult to build a cohesive message as the Democratic National Committee (DNC) has been embroiled in…
Democratic Leadership Is Complacent In The Face Of Iran War Threat
June 20, 2025
Take Action Now “It’s embarrassing that some problematic far-right figures are speaking out more forcefully against direct military…
The Revolution Will Not Be Digitized: A “No Kings” Debrief
June 19, 2025
Take Action Now What worked, what didn’t—and what about Gaza?By RJ Eskow, The Zero Hour Report The “after-action review” is an exercise that the…